Citations

Mayo Clinic

Clear

778 citation(s) found for "Yañez, Eduardo".

HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis
Brum, Doralina Guimarães , Barreira, Amilton Antunes , Kaimen-Maciel, Damacio Ramón , Matiello, Marcelo , Deghaide, Neifi Hassan Saloun, Costa, Laudo Silva, Louzada‐Júnior, Paulo , Diniz, Paula Rejane Beserra , Mendes‐Junior, Celso Teixeira , Donadi, Eduardo Antônio , Santos, Antônio Carlos dos , Costa, Roberta Martins da Silva , Comini-Frota, Elizabeth Regina

Multiple Sclerosis Journal | December 7, 2009 | Volume: 16 | Issue: 1 | Pages: 21-29

10.1177/1352458509350741 | PMID 19995845 Get It

Until recently, neuromyelitis optica (NMO) was considered to be a sub-type of multiple sclerosis (MS), which has a strong predilection for Caucasian populations, whereas NMO is more frequent in non-Caucasian individuals. The objective of this study was to compare the HLA-DRB profile in Brazilian Mulatto patients with NMO spectrum disorders (NMOSDs) with that observed for Mulatto MS patients and healthy Mulatto controls. Twenty seven NMOSD patients (20 women), all seropositive for NMO-IgG, 29 MS patients and 28 Mulatto healthy blood donors were evaluated for HLA-DRB allele groups. HLA-DRB1*03 allele group was overrepresented in NMO patients compared with healthy controls (p = 0.0401; OR = 3.23, 95%CI: 1.07—9.82). In contrast, the HLA-DRB1*15 allele group was overrepresented in Brazilian MS patients (OR = 15.89, 95%CI: 3.51—71.85; p < 0.0001). DRB3 was overrepresented in NMO (p = 0.0064), and DRB5 overrepresented in MS patients (p = 0.0001). The low frequency of HLA-DRB1*15 alleles was associated with the presence of long and central cord lesions at magnetic resonance. In addition, DRB1*15 alleles were associated with the fulfillment of the Barkhof criteria. In conclusion, these results indicate that the DRB profile of NMO patients is different from that observed for MS patients, further corroborating the distinction between NMO and MS.
The locus ceruleus norepinephrine system
Benarroch, Eduardo E.

Neurology | November 16, 2009 | Volume: 73 | Issue: 20 | Pages: 1699-1704

10.1212/wnl.0b013e3181c2937c | PMID 19917994 Get It

Astrocyte-neuron interactions
Benarroch, Eduardo E.

Neurology | October 19, 2009 | Volume: 73 | Issue: 16 | Pages: 1323-1327

10.1212/wnl.0b013e3181bd432d | PMID 19841385 Get It

Serotonergic modulation of basal ganglia circuits
Benarroch, Eduardo E.

Neurology | September 14, 2009 | Volume: 73 | Issue: 11 | Pages: 880-886

10.1212/wnl.0b013e3181b784e7 | PMID 19752456 Get It

Hypoxia-induced mediators and neurologic disease
Benarroch, Eduardo E.

Neurology | August 17, 2009 | Volume: 73 | Issue: 7 | Pages: 560-565

10.1212/wnl.0b013e3181b2a719 | PMID 19687457 Get It

Autonomic-mediated immunomodulation and potential clinical relevance
Benarroch, Eduardo E.

Neurology | July 20, 2009 | Volume: 73 | Issue: 3 | Pages: 236-242

10.1212/wnl.0b013e3181aebd43 | PMID 19620613 Get It

Dopamine cell loss in the periaqueductal gray in multiple system atrophy and Lewy body dementia
Benarroch, Eduardo E. , Schmeichel, Ann M., Dugger, Brittany N. , Sandroni, Paola , Parisi, Joseph E., Low, Phillip A. , Dugger, Brittany N

Neurology | July 13, 2009 | Volume: 73 | Issue: 2 | Pages: 106-112

10.1212/wnl.0b013e3181ad53e7 | PMID 19597132 Get It

Oligodendrocytes
Benarroch, Eduardo E.

Neurology | May 18, 2009 | Volume: 72 | Issue: 20 | Pages: 1779-1785

10.1212/wnl.0b013e3181a6b123 | PMID 19451534 Get It

Brain iron homeostasis and neurodegenerative disease
Benarroch, Eduardo E.

Neurology | April 20, 2009 | Volume: 72 | Issue: 16 | Pages: 1436-1440

10.1212/wnl.0b013e3181a26b30 | PMID 19380704 Get It

Neuropeptide Y
Benarroch, Eduardo E.

Neurology | March 16, 2009 | Volume: 72 | Issue: 11 | Pages: 1016-1020

10.1212/01.wnl.0000345258.18071.54 | PMID 19289742 Get It